For all the exciting developments in the synthetic biology industry, there are also concerns.

People can edit genes in their garages these days, so who’s regulating this space?

Plus - we’ll hear about the exciting new business models with biology at their core, including one of the first synbio businesses to trade as a public stock - Ginkgo Bioworks.

Presenter: Gareth Mitchell

(Image: A petri dish in a lab. Credit: Getty Images)